Procurement Summary
Country : Brazil
Summary : Acquisition of Medicines, Aiming at the Care of Patients Registered in the Dispensing Units of Sespa.
Deadline : 03 Jun 2025
Other Information
Notice Type : Tender
TOT Ref.No.: 119609524
Document Ref. No. : 90012/2025
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
Object: Electronic Auction - Acquisition of Medicines, aiming at the care of patients registered in Sespa's dispensing units.Concentration 400 mg
Quantity: 92700
mesalazine, concentration 500 mg
Quantity: 1500
mesalazine, concentration 800 mg
Quantity: 425000
table, concentration 1200 mg, pharmaceutical form prolonged
quantity: 25000
methylprednisolone, active ingredient succinato, dosage 500 mg, Lyophilized presentation + diluent, injectable
quantity: 11250
mycophenolate, mofethyl composition, concentration 500 mg
quantity: 100000
mycophenolate, sodium composition, concentration 180 mg
quantity: 30000
mycophenolate, sodium composition, concentration 360 mg
quantity
Morphine, Sulfate Presentation, 30mg concentration, pharmaceutical form liberation of the degree
Quantity: 14000
morphine, sulfate presentation, 10mg/ml concentration, pharmaceutical form injectable solution
Quantity: 2700
octreotida, acetate salt composition, 10 mg concentration, pharmaceutical form liophilic powderInjectable, additional feature w/ application system
Quantity: 150
omalizumab, concentration 150 mg, injectable pharmaceutical form
Quantity: 5250
pancreatic enzymes, active ingredient pancreatine (amylase + lipase + protease), dosage 10, 000 UI: 75000
pancreatic enzymes, Active Principle Pancreatine (amylase + lipase + protease), concentration 25, 000 UI
Quantity: 170000
penicillamine, dosage 250 mg
Quantity: 10500
pyridostigmine bromide, dosage 60 mg
quantity: 120000
rolochron, concentration 60 mg
quantity: 7500
risedronate, concentration35 mg, additional controlled release ...
Documents
Tender Notice